 | • レポートコード：B-MOR-05097 • 出版社/出版日：Mordor Intelligence / 2018年3月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、生検装置の世界市場について調べ、生検装置の世界規模、市場動向、市場環境、製品別分析、用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・生検装置の世界市場インサイト ・生検装置の世界市場環境 ・生検装置の世界市場動向 ・生検装置の世界市場規模 ・生検装置の世界市場規模：製品別 ・生検装置の世界市場規模：用途別 ・生検装置の世界市場：地域別市場規模・分析 ・生検装置の北米市場規模・予測 ・生検装置のアメリカ市場規模・予測 ・生検装置のヨーロッパ市場規模・予測 ・生検装置のアジア市場規模・予測 ・生検装置の日本市場規模・予測 ・生検装置の中国市場規模・予測 ・生検装置のインド市場規模・予測 ・生検装置の韓国市場規模・予測 ・関連企業情報・競争状況 |
A biopsy can be described as a process in which a sample tissue is removed from the body for analyzing or discovering the presence, cause, or extent of a disease. The global biopsy devices market is expected to register a CAGR of 6.5% during the forecast period (2018 – 2023).
Increase in the Number of Cancers Cases Worldwide
Cancer prevalence indicates the number of people who were diagnosed with cancer in their lifetime. Prevalence is determined by the repetition of occurrence of cancer and the life expectancy of the patient after diagnosis. The key facts stated by WHO projects cancer to be one of the leading causes of mortality worldwide, with around 14 million new cases and 8.2 million cancer-related deaths in 2012. The number of new cases is expected to rise by 70% in the next two decades. The demand for early detection of the cancer is going to influence the growth of the biopsy devices market in the world over.
Increasing preference for minimally-invasive surgeries and initiatives undertaken by the government and global health organizations, are some of the other factors contributing to the growth of the market.
Risk of Infection
A biopsy is often the key to diagnosis. However, as some of these devices are being re-used, biopsy needle becomes a highly risky source of infection and micro-organisms get inoculated into the body. The needles used for biopsy can never be effectively cleaned or sterilized, and reuse of it can cause the spread of blood borne pathogens, like Hepatitis-B, Hepatitis-C, and HIV, as well as other micro-organisms like atypical mycobacteria, gram negative bacteria, and various fungi infections.
Additionally, increasing product recalls, due to unmet regulations, is also restraining the global biopsy devices market growth.
Asia-Pacific to have the Highest CAGR
The global biopsy devices market is segmented by product, application and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
The growth of Asia-Pacific can be attributed to the rising prevalence of cancer, large population in countries such as China and India, improving healthcare infrastructure, increasing healthcare spending and government initiatives, and rising focus of key market players in the region.
Key Developments in the Market
• August 2017: C. R. Bard Receives FDA pPremarket approval of the LUTONIX® 035 drug coated balloon as the first and only DCB for the treatment of patients with dysfunctional AV fistulae
• August 2017: Hologic announced the availability of New Brevera® Breast Biopsy System, with CorLumina® Imaging Technology
Major Players: C R BARD, HOLOGIC, CAREFUSION, DEVICOR MEDICAL PRODUCTS, COOK MEDICAL, BOSTON SCIENTIFIC, INTACT MEDICAL CORPORATION, GALLINI MEDICAL DEVICES, AND TSK LABORATORY, amongst others.
Reasons to Purchase The Report
• Market analysis for the Global Biopsy Devices Market, with region-specific assessments and competition analysis on a global and regional scale
• Analyze various perspectives of the industry with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness the fastest growth, during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 month analyst support, along with the market estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Preference for Minimally Invasive Surgeries
6.1.2 Initiatives Undertaken by Government and Global Health Organizations
6.1.3 Increase in the Number of Cancer Cases Worldwide
6.2 Market Restraints
6.2.1 Product Recalls
6.2.2 Risk of Infections
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product
7.1.1 Needle-based biopsy Instruments
7.1.1.1 Core Biopsy Devices
7.1.1.2 Aspiration Biopsy Needles
7.1.1.3 Vacuum-Assisted Biopsy Devices
7.1.2 Procedure Trays
7.1.3 Localization Wires
7.1.4 Others
7.2 By Application
7.2.1 Breast Biopsy
7.2.2 Lung Biopsy
7.2.3 Colorectal Biopsy
7.2.4 Prostate Biopsy
7.2.5 Others
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 United Kingdom
7.3.2.3 Germany
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 India
7.3.3.2 China
7.3.3.3 Japan
7.3.3.4 Australia
7.3.3.5 South Korea
7.3.3.6 Rest of APAC
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches
9. Key Players
9.1 C R Bard
9.2 Hologic
9.3 Carefusion
9.4 Devicor Medical Products
9.5 Cook Medical
9.6 Boston Scientific
9.7 Intact Medical Corporation
9.8 Gallini Medical Devices
9.9 TSK Laboratory
9.10 Others
10. Future of the Market